SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis.

Negro, Aurelio; Fama, Angelo; Penna, Domenico; Belloni, Lucia; Zerbini, Alessandro; Giuri, Pasquale Gianluca

Negro, Aurelio; Fama, Angelo; Penna, Domenico; Belloni, Lucia; Zerbini, Alessandro; Giuri, Pasquale Gianluca.

Negro A; Internal Medicine and Secondary Hypertension Center, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Sant'Anna Hospital, Castelnovo ne' Monti, Italy.
Fama A; Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.
Penna D; Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy.
Belloni L; PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Zerbini A; Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Giuri PG; Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Am J Hematol ; 96(2): E41-E43, 2021 02 01.

Article in English | MEDLINE | ID: covidwho-891870

Subject(s)

COVID-19; Thrombosis; Angiotensin II; Humans; Placenta Growth Factor; SARS-CoV-2; Thrombosis/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombosis / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26037

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google